2008
DOI: 10.1016/j.ejphar.2008.08.015
|View full text |Cite
|
Sign up to set email alerts
|

Stimulus properties of venlafaxine in a conditioned taste aversion procedure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 30 publications
0
4
0
Order By: Relevance
“…As noted above, drug preexposure has been reported to attenuate the acquisition of taste avoidance, and the two drugs examined here have been used in such designs and have been shown to impact avoidance induced by other drugs (fluoxetine) and are impacted by drug history (MDMA). For example, fluoxetine preexposure attenuates avoidance induced by a variety of drugs including LiCl (Lorden & Nunn, 1982), MK212, 8-OH-DPAT and 2,5-dimethoxy-4-iodoamphetamine (Berendsen & Broekkamp, 1994), mirtazapine (Berendsen & Broekkamp, 1997), fluvoxamine (Gommans et al, 1998; see Olivier et al, 1999 for partial attenuation), cocaine (Jones et al, 2009; though see Serafine & Riley, 2013), and venlafaxine (Kayir et al, 2008). Further, MDMA-induced taste avoidance can be attenuated by prior exposure to MDMA.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As noted above, drug preexposure has been reported to attenuate the acquisition of taste avoidance, and the two drugs examined here have been used in such designs and have been shown to impact avoidance induced by other drugs (fluoxetine) and are impacted by drug history (MDMA). For example, fluoxetine preexposure attenuates avoidance induced by a variety of drugs including LiCl (Lorden & Nunn, 1982), MK212, 8-OH-DPAT and 2,5-dimethoxy-4-iodoamphetamine (Berendsen & Broekkamp, 1994), mirtazapine (Berendsen & Broekkamp, 1997), fluvoxamine (Gommans et al, 1998; see Olivier et al, 1999 for partial attenuation), cocaine (Jones et al, 2009; though see Serafine & Riley, 2013), and venlafaxine (Kayir et al, 2008). Further, MDMA-induced taste avoidance can be attenuated by prior exposure to MDMA.…”
Section: Discussionmentioning
confidence: 99%
“…Fluoxetine hydrochloride (Sigma) was dissolved in distilled water at a concentration of 5 mg/ml and injected subcutaneously (SC) at 10 mg/kg. This dose was selected based on research reporting that preexposure of fluoxetine at 10 mg/kg is effective in attenuating taste avoidance induced by a variety of other drugs (see Berendsen & Broekkamp, 1994; Kayir et al, 2008; Lorden & Nunn, 1982). MDMA (3, 4-MDMA hydrochloride, generously provided by the National Institute on Drug Abuse [NIDA] drug supply program) was dissolved in isotonic saline (0.9%) at a concentration of 2 mg/ml and injected SC at a dose of 3.2 mg/kg.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Given that these compounds (ipsapirone, buspirone, RU-24969, sertraline, d-amphetamine, LSD, metergoline and idazoxane) were effective in blocking 8-OHDPAT-induced CTAs, De Beun and colleagues concluded that cross-drug preexposure could be used to assess the commonalities in aversion-inducing mechanism between different compounds (De Beun et al, 1993). Since this demonstration, several other investigations have also utilized this procedure to examine common mechanisms in the aversive effects of various compounds (see De Beun et al, 1996; Gommans et al, 1998; Jones et al, 2009; Kayir et al, 2008; Olivier et al, 1999; Van Hest et al, 1992; Serafine and Riley, 2009; 2010). …”
Section: Introductionmentioning
confidence: 99%